Client Reported $ Filings Share
ELUSYS THERAPEUTICS INC FKA NIGHTHAWK BIOSCIENCES, INC. $700.0K 3

0 of 2 lobbyists (0%) listed a prior covered government position on a lobbying filing.

2 reports on file for 2025 (latest version of each); 0 reported no contributions.

Itemized by year

Largest recipients, 2025

Posted Period Client Type Income Expenses Activities Lobbyists
2026-07-18 2026 Q2 ELUSYS THERAPEUTICS INC FKA NIGHTHAWK BIOSCIENCES, INC. 2nd Quarter - Report — $280.0K 2 2
2026-04-20 2026 Q1 ELUSYS THERAPEUTICS INC FKA NIGHTHAWK BIOSCIENCES, INC. 1st Quarter - Report — $220.0K 2 1
2026-01-21 2025 Q4 ELUSYS THERAPEUTICS INC FKA NIGHTHAWK BIOSCIENCES, INC. 4th Quarter - Report — $200.0K 2 1
2025-10-21 2025 Q3 ELUSYS THERAPEUTICS INC FKA NIGHTHAWK BIOSCIENCES, INC. 3rd Quarter - Report — $150.0K 2 1
2025-07-21 2025 Q2 ELUSYS THERAPEUTICS INC FKA NIGHTHAWK BIOSCIENCES, INC. 2nd Quarter - Report — $220.0K 2 1
2025-04-21 2025 Q1 ELUSYS THERAPEUTICS INC FKA NIGHTHAWK BIOSCIENCES, INC. 1st Quarter - Report — $200.0K 2 1
2025-01-20 2024 Q4 ELUSYS THERAPEUTICS INC FKA NIGHTHAWK BIOSCIENCES, INC. 4th Quarter - Report — $170.0K 2 1
2024-10-21 2024 Q3 ELUSYS THERAPEUTICS INC FKA NIGHTHAWK BIOSCIENCES, INC. 3rd Quarter - Report — $130.0K 2 1
2024-07-19 2024 Q2 ELUSYS THERAPEUTICS INC FKA NIGHTHAWK BIOSCIENCES, INC. 2nd Quarter - Report — $110.0K 2 1
2024-04-22 2024 Q1 ELUSYS THERAPEUTICS INC FKA NIGHTHAWK BIOSCIENCES, INC. 1st Quarter - Report — $130.0K 2 1
  • ANNE CHESTER
  • RYAN KANE

Source: LDA.gov, data retrieved November 17, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.